Literature DB >> 16557700

Production of Biologically Active Substances by Two Strains of Vibrio cholerae.

H Kusama1, J P Craig.   

Abstract

Strains Inaba 569B and Ogawa B1307 of Vibrio cholerae were grown in shaken Casamino Acids-yeast extract-glucose medium at 30 and 37 C for 4 days. Time courses of production of neuraminidase (NM), mucinase (MC), proteinase (PR), lytic factor (LF), and vascular permeability factor (PF) were compared by examining culture filtrates taken at various intervals. With both strains, turbidities were generally higher at 30 C than at 37 C. Both strains showed marked cellular lysis after maximal growth was attained at 48 hr at both temperatures. NM and PF were early products, maximal yield being attained within 24 hr. At 37 C, the peak of NM reached at about 10 hr was higher than at 30 C, but disappeared more quickly. The yield of PF was greater at 30 C than at 37 C, and 569B produced more PF. With 569B, PF appeared during the exponential phase, but continued to increase substantially after this phase terminated. At 30 C, the peak attained at 24 hr by 569B was well maintained until 96 hr, but fell moderately at 37 C. In contrast, with B1307 PF fell sharply and virtually disappeared after 24 hr at both temperatures, with concomitant rise in late products. PR and LF were late products; neither was detected in 569B filtrates, whereas older cultures of B1307 showed high levels of both enzymes. MC was an early product with 569B, resembling PF, whereas it was a late product with B1307.

Entities:  

Year:  1970        PMID: 16557700      PMCID: PMC415859          DOI: 10.1128/iai.1.1.80-87.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Role of cholera a toxin in experimental cholera.

Authors:  N K DUTTA; M V PANSE; D R KULKARNI
Journal:  J Bacteriol       Date:  1959-10       Impact factor: 3.490

2.  Stimulation of the production of neuraminidase in Vibrio cholerae cultures by N-acetylneuraminic acid and sialyl-lactose.

Authors:  E L FRENCH; G L ADA
Journal:  J Gen Microbiol       Date:  1959-12

3.  The serologic character of cholera Vibrio mucinase.

Authors:  R FRETER
Journal:  J Infect Dis       Date:  1955 Nov-Dec       Impact factor: 5.226

Review 4.  Cholera toxins.

Authors:  W Burrows
Journal:  Annu Rev Microbiol       Date:  1968       Impact factor: 15.500

5.  Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A.

Authors:  R A Finkelstein; P Atthasampunna; M Chulasamaya; P Charunmethee
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

6.  In vitro production of choleragen and vascular permeability factor by Vibrio cholerae.

Authors:  D J Evans; S H Richardson
Journal:  J Bacteriol       Date:  1968-07       Impact factor: 3.490

7.  A permeability factor (toxin) found in cholera stools and culture filtrates and its neutralization by convalescent cholera sera.

Authors:  J P Craig
Journal:  Nature       Date:  1965-08-07       Impact factor: 49.962

8.  Preparation of the vascular permeability factor of Vibrio cholerae.

Authors:  J P Craig
Journal:  J Bacteriol       Date:  1966-09       Impact factor: 3.490

9.  Hemolysin-destructive factor of Vibrio cholerae (Vibrio comma).

Authors:  A Wake; M Yamamoto
Journal:  J Bacteriol       Date:  1966-01       Impact factor: 3.490

10.  Site and characteristics of electrolyte loss and effect of intraluminal glucose in experimental canine cholera.

Authors:  C C Carpenter; R B Sack; J C Feeley; R W Steenberg
Journal:  J Clin Invest       Date:  1968-05       Impact factor: 14.808

View more
  19 in total

1.  Immunochemical characterization of synthetic hexa-, octa- and decasaccharide conjugate vaccines for Vibrio cholerae O:1 serotype Ogawa with emphasis on antigenic density and chain length.

Authors:  Peter Ftacek; Victor Nelson; Shousun C Szu
Journal:  Glycoconj J       Date:  2013-08-17       Impact factor: 2.916

2.  Comparison of a latex agglutination assay and an enzyme-linked immunosorbent assay for detecting cholera toxin.

Authors:  R J Almeida; F W Hickman-Brenner; E G Sowers; N D Puhr; J J Farmer; I K Wachsmuth
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

3.  Vibrio cholerae expresses cell surface antigens during intestinal infection which are not expressed during in vitro culture.

Authors:  G Jonson; A M Svennerholm; J Holmgren
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

4.  Large production of cholera toxin by Vibrio cholerae O1 in yeast extract peptone water.

Authors:  M Iwanaga; T Kuyyakanond
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

Review 5.  Vibrio cholerae enterotoxin and its mode of action.

Authors:  N F Pierce; W B Greenough; C C Carpenter
Journal:  Bacteriol Rev       Date:  1971-03

6.  Enzymes of non-agglutinable vibrios and their possible role in the development of enterotoxic factor.

Authors:  B Guhathakurta; S Bhattacharya; G C Datta; A K Ghosh
Journal:  Experientia       Date:  1973

7.  Biochemistry of Vibrio cholerae virulence. 3. Nutritional requirements for toxin production and the effects of pH on toxin elaboration in chemically defined media.

Authors:  L T Callahan; S H Richardson
Journal:  Infect Immun       Date:  1973-04       Impact factor: 3.441

8.  Uptake of Vibrio cholerae biotype eltor from contaminated water by water hyacinth (eichornia crassipes).

Authors:  W M Spira; A Huq; Q S Ahmed; Y A Saeed
Journal:  Appl Environ Microbiol       Date:  1981-09       Impact factor: 4.792

9.  Production of cholera toxin-like toxin by Vibrio mimicus and non-O1 Vibrio cholerae: batch culture conditions for optimum yields and isolation of hypertoxigenic lincomycin-resistant mutants.

Authors:  W M Spira; P J Fedorka-Cray
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

10.  Colonization of the rabbit small intestine by clinical and environmental isolates of non-O1 Vibrio cholerae and Vibrio mimicus.

Authors:  W M Spira; P J Fedorka-Cray; P Pettebone
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.